Latest filing published 23 Apr 2026 for Day One Biopharmaceuticals, Inc..
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
All filings by John A. Josey on record concern Day One Biopharmaceuticals, Inc., in the capacity of board member. In total, 2 filings cover trades dated from 1 June 2021 to 23 April 2026.
Every open-market trade on record is a purchase: 1 purchase worth €92k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The newest entry dates from 23 April 2026: a transaction, in Day One Biopharmaceuticals, Inc. The last purchase on record was published on 1 June 2021, which is 1,974 days ago. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations